PODD

262.00

1.72% -4.58

Handel nachbörslich: 262.00

Insulet Corporation (PODD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PODD? Forum Prognose

Schlusskurs vom Vortag:

$266.58

Offen:

$267.43

24-Stunden-Volumen:

688.09K

Relative Volume:

1.12

Marktkapitalisierung:

$18.38B

Einnahmen:

$1.87B

Nettoeinkommen (Verlust:

$395.30M

KGV:

153.22

EPS:

1.71

Netto-Cashflow:

$182.40M

1W Leistung:

+0.32%

1M Leistung:

+10.79%

6M Leistung:

+43.33%

1J Leistung:

+44.50%

1-Tages-Spanne:

$261.92

$267.43

1-Wochen-Bereich:

$257.43

$267.43

52-Wochen-Spanne:

$160.19

$279.40

Insulet Corporation Stock (PODD) Company Profile

Firmenname

Insulet Corporation

Sektor

Healthcare (1195)

Branche

Medical Devices (153)

Telefon

978-600-7000

Adresse

100 NAGOG PARK, ACTON, MA

Mitarbeiter

3,000

Twitter

@insulet_uk

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PODD's Discussions on Twitter

Vergleichen Sie PODD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PODD	262.00	18.38B	1.87B	395.30M	182.40M	1.71
ABT	117.26	201.11B	41.22B	5.77B	6.49B	2.94
SYK	390.14	148.40B	21.97B	3.59B	3.21B	6.74
BSX	91.50	134.72B	15.91B	1.79B	1.89B	0.82
MDT	84.74	108.57B	33.00B	4.29B	5.50B	2.71
EW	70.38	41.51B	6.60B	4.16B	490.10M	2.34

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2023-12-04	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Hochstufung	Jefferies	Hold → Buy
2023-08-21	Hochstufung	Citigroup	Neutral → Buy
2023-08-21	Herabstufung	Robert W. Baird	Outperform → Neutral
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-04	Hochstufung	Piper Sandler	Neutral → Overweight
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-03	Hochstufung	BTIG Research	Neutral → Buy
2022-02-02	Hochstufung	UBS	Neutral → Buy
2022-01-31	Hochstufung	Oppenheimer	Perform → Outperform
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-01	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Hochstufung	Canaccord Genuity	Hold → Buy
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-07-28	Eingeleitet	Wells Fargo	Overweight
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Eingeleitet	BofA/Merrill	Neutral
2020-03-31	Herabstufung	Berenberg	Buy → Hold
2020-03-05	Eingeleitet	Citigroup	Buy
2019-12-10	Eingeleitet	CFRA	Sell
2019-10-23	Eingeleitet	Stifel	Hold
2019-10-18	Herabstufung	Canaccord Genuity	Buy → Hold
2019-10-14	Herabstufung	BTIG Research	Buy → Neutral
2019-10-04	Herabstufung	UBS	Buy → Neutral
2019-10-03	Herabstufung	Guggenheim	Buy → Neutral
2019-08-06	Hochstufung	JP Morgan	Neutral → Overweight
2019-06-10	Herabstufung	Northland Capital	Outperform → Market Perform
2019-05-06	Hochstufung	BTIG Research	Neutral → Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-02-22	Bestätigt	Barclays	Overweight
2018-01-08	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-11-03	Hochstufung	Canaccord Genuity	Hold → Buy
2017-09-15	Eingeleitet	Barclays	Overweight

Alle ansehen

Insulet Corporation Aktie (PODD) Neueste Nachrichten

10:49 AM

PODDInsulet Corporation Latest Stock News & Market Updates - StockTitan

10:49 AM

08:52 AM

Brown Capital Management LLC Sells 11,147 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

08:52 AM

08:27 AM

Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster - Yahoo Finance

08:27 AM

07:55 AM

Insulet: Superb Business Growth, Starting Valuations Outsized Risk (NASDAQ:PODD) - Seeking Alpha

07:55 AM

05:17 AM

Segall Bryant & Hamill LLC Has $14.68 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat

05:17 AM

Nov 20, 2024

Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth - Insider Monkey

Nov 20, 2024

Insulet Corporation: Significant Opportunities, Significant ThreatsI'm On The Sidelines - Seeking Alpha

Nov 20, 2024

Indexes Show More Strength, Pare Losses: Blue Owl, Chewy, Insulet In FocusVideoIBD - Investor's Business Daily

Nov 20, 2024

Insulet To Present At Wolfe Research Healthcare Conference; Webcast At 12:00 PM ET - Nasdaq

Nov 20, 2024

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More - MSN

Nov 20, 2024

Insulet's Omnipod 5 Expands Leadership with FreeStyle Libre 2 Plus Integration | PODD Stock News - StockTitan

Nov 20, 2024

Nov 19, 2024

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - MSN

Nov 19, 2024

15,111 Shares in Insulet Co. (NASDAQ:PODD) Acquired by LMR Partners LLP - MarketBeat

Nov 19, 2024

Nov 17, 2024

Insulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Nov 17, 2024

Nov 16, 2024

Insulet Corp - Cyber Magazine

Nov 16, 2024

Mizuho Securities USA LLC Boosts Position in Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 16, 2024

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals - Yahoo Finance

Nov 16, 2024

GSA Capital Partners LLP Acquires Shares of 4,370 Insulet Co. (NASDAQ:PODD) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options - Nasdaq

Nov 15, 2024

Insulet to Present at Major Healthcare Conferences, Showcasing Omnipod 5 Innovation | PODD Stock News - StockTitan

Nov 15, 2024

Nov 14, 2024

William Blair Has Optimistic Outlook of Insulet Q3 Earnings - MarketBeat

Nov 14, 2024

Insulet Co. (NASDAQ:PODD) Shares Bought by Principal Financial Group Inc. - MarketBeat

Nov 14, 2024

Nov 13, 2024

Insulet corp director Luciana Borio sells $139,598 in stock - Investing.com

Nov 13, 2024

Insider Sale: Director Luciana Borio Sells Shares of Insulet Cor - GuruFocus.com

Nov 13, 2024

Insulet corp director Luciana Borio sells $139,598 in stock By Investing.com - Investing.com UK

Nov 13, 2024

William Blair Issues Optimistic Outlook for Insulet Earnings - MarketBeat

Nov 13, 2024

Insulet Co. (NASDAQ:PODD) Shares Sold by Los Angeles Capital Management LLC - MarketBeat

Nov 13, 2024

Capital Research Global Investors Expands Stake in Insulet Corp - GuruFocus.com

Nov 13, 2024

Insulet's SWOT analysis: diabetes tech leader faces competition in pump market - Investing.com

Nov 13, 2024

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up - Yahoo Finance

Nov 12, 2024

Insulet price target raised to $317 from $234 at Morgan Stanley - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Barclays raises Insulet stock price target following robust Q3 beat By Investing.com - Investing.com Canada

Nov 11, 2024

Barclays raises Insulet stock price target following robust Q3 beat - Investing.com India

Nov 11, 2024

Barclays Increases Insulet (NASDAQ:PODD) Price Target to $234.00 - MarketBeat

Nov 11, 2024

Morgan Stanley Raises Insulet (NASDAQ:PODD) Price Target to $317.00 - MarketBeat

Nov 11, 2024